1.50Open1.50Pre Close0 Volume739 Open Interest10.00Strike Price0.00Turnover109.92%IV-0.61%PremiumDec 20, 2024Expiry Date1.57Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8632Delta0.1322Gamma6.81Leverage Ratio-0.0302Theta0.0014Rho5.87Eff Leverage0.0033Vega
Indivior Stock Discussion
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced preliminary Q3 2024 financial results and provided updated FY 2024 guidance.
• Group now sees lower than expected Q3 2024 and FY 2024 SUBLOCADE net revenue (NR) from a combination of faster initial adoption among treatment providers of the...
No comment yet